Understanding how peanut allergy affects the gut barrier
Revealing the mechanisms of increased intestinal epithelial cell barrier permeability in peanut allergy
This study is looking into why people with peanut allergies have a leaky gut, which can make their allergic reactions worse, and it hopes to find new ways to help improve their health by focusing on the gut.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10887064 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind increased permeability of the intestinal epithelial cell barrier in individuals with peanut allergies. The study aims to uncover how this dysfunction contributes to allergic reactions and seeks to develop new therapies targeting the gut to improve patient outcomes. The research will involve a combination of laboratory experiments and analysis of human data to gain insights into the biological processes at play. By collaborating with experts in various fields, the project aims to build a strong foundation for future advancements in allergy treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with peanut allergies, particularly those experiencing severe allergic reactions.
Not a fit: Patients without peanut allergies or those with mild allergies that do not involve intestinal symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve gut health and reduce severe allergic reactions in patients with peanut allergies.
How similar studies have performed: Previous research has shown promising results in understanding gut barrier dysfunction in other allergic conditions, suggesting potential for success in this area as well.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Steinbach, Erin C. — Univ of North Carolina Chapel Hill
- Study coordinator: Steinbach, Erin C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.